What’s holding back cultivated meat?

What’s holding back cultivated meat?

Early products have certainly generated interest, but supply constraints, regulatory hurdles and the cost of scaling are delaying wider commercial adoption.

Despite successful feeding trials and early demand signals, progress is stalling at some companies that have developed cultivated meat pet foods due to limitations in the supply of their star ingredient or the difficulties of scaling production.

The prospect is there

Figures in the industry say they still see significant potential in cultivated meat – provided it can be produced at scale for a reasonable cost.

“It’s super exciting, super promising, but for it to work I think it needs a lot of funding and a lot of time,” says Dr. Guy Sandelowsky, a veterinarian and co-founder of UK pet food player Omni. “It’s one to watch but for a company like ours that is already selling, for us it felt like too much of a risk at this stage.”

Not ready for retail

Omni launched what it billed as the world’s first cruelty-free complete cat food in April 2024, after it developed a canned food product with cultivated chicken meat. The prototype looked promising, according to Dr. Sandelowsky, but Omni suspended production a few months later when the company realized it would be unable to sustain the product long term.

“The product itself is really exciting, but there just wasn’t the volume,” Dr. Sandelowsky says, noting that a cat food customer would purchase dozens of cans of food each month. “There was just no way any [cultivated meat producer was] going to be able to supply us enough at a price point that made sense for us.

“We were bought into the hype, otherwise we wouldn’t have created a prototype, but then a few months later our experience was that production wasn’t possible.”

Testing the market

Other pet food firms have also trialed cultivated meat products but stopped short of launching them widely. THE PACK offered a limited run of cultivated meat dog treats called Chick Bites at UK pet retailer Pets at Home in February 2025; the treats sold out quickly and are no longer on the market pending expanded production at supplier Meatly, according to Meatly CEO Owen Ensor.

Nasta Petfood also debuted a complete cultivated meat food for dogs called Coolty Meat under its FORZA10 brand at Interzoo 2026 in May. Irache Martinez, Chief Marketing Officer at Nasta, says that since the announcement the company has received inquiries “from all over the world, across Europe, the UK, Asia and even the US, from retailers, distributors and media”.

Coolty Meat is capitalizing on interest with a pilot across four retailers in Spain and four in Portugal.

Alongside sales data from the pilots, a consumer satisfaction survey will assess why owners make repeat purchases and how they perceive the concept. After this phase, the company plans to expand Coolty Meat to additional European countries in 2027.

Driving demand

Europe remains a strong market for alternative proteins, but BeneMeat has also received inquiries from North America and parts of Asia. By segment, Míčková states that “the strongest demand is consistently coming from the premium and clinical pet nutrition sectors”, particularly from brands focused on specialized veterinary lines and clean-label products positioned around longevity.

“Because it is produced in a strictly closed environment, our cultivated meat ingredient can help eliminate the risk of external contamination. The ingredient is produced with no antibiotics and contains no added hormones,” Míčková explains.

This focus underpinned the partnership with FORZA10, as the brand already targets pets with food intolerances. Its portfolio includes single-protein and single-grain recipes for sensitive dogs.

Feeding trials

Despite his recent experience, Dr. Sandelowsky is still a fan of the cultivated meat concept. Like other pet food manufacturers, he’s primarily interested in the sustainability benefits of reduced meat consumption.

And he views cultivated meat as uniquely able to meet the niche needs of cats – who did seem to enjoy the prototype food Omni developed. He says: “We had a few cats try the product and they loved it, but we didn’t get to the proper large-scale feeding stage.”

Meatly’s Ensor called the quick sellout of Chick Bites a clear sign of demand from consumers. And BeneMeat had a similar experience with its Try & Share Program, which gives participants early access to samples of cultivated meat. Míčková reveals that a dog treat distributed through the program received rave reviews, with 86% of participating users saying they would buy the treats again.

BeneMeat recently collaborated with Ghent University in Belgium on a first-of-its-kind feeding trial in which cats were offered a mousse of either conventional chicken meat or cultivated hamster meat. The hamster meat proved modestly less digestible than the chicken, but possibly more popular. The cats left fewer hamster mousse leftovers – though one of the 10 cats in the trial did outright refuse to eat it.

Evidence gathering

That trial highlighted another interesting aspect of cultivated meat production, according to Federica Bortolazzi, a PhD student at Ghent University and one of the authors of the study.

Cats may eat rodents by instinct, but nobody is raising rodents en masse for inclusion in pet food. Growing the meat in a lab could open up new protein options for picky or sensitive eaters, or for pet owners looking to try something new.

But the results of the study may not be transferable to more widely available cultivated meats, such as cultivated chicken, Bortolazzi explains. And regardless of protein, she notes that there’s still a need for large-scale feeding trials to verify long-term health outcomes before cultivated meat is accepted as a mainstream protein.

Regulatory hurdles

While the research and development behind cultivated meat continues apace, Míčková points out that the regulatory landscape is another matter entirely. “To be completely frank,” she says, “our rapid R&D and technological advancements have significantly outpaced current legislative frameworks.”

BeneMeat has secured regulatory recognition in the EU, which enabled the production of Coolty Meat, while Meatly used the UK’s recent ‘regulatory sandbox’ for cultivated meat products to advance approvals there.

“Brexit created an opportunity for the UK to lead in food biotechnology, and the UK took it,” Ensor says, describing the Department for Environment, Food & Rural Affairs (DEFRA), Department for Science, Innovation and Technology (DSIT) and Food Standards Agency (FSA) as “genuine pioneers in alternative proteins”.

But when it comes to accessing other markets or scaling production globally, Míčková says regulatory delays have become “the primary bottleneck for full market integration”.

Dr. Sandelowsky agrees, noting that regulatory hurdles to selling pet food made with cultivated meat were among the reasons why Omni chose to put its plans for a cat food product on hold. But the issue really holding cultivated meat back, he says, is scale.

Racing to scale

Both Meatly and BeneMeat are working to address that problem.

Meatly plans to construct a 20,000-liter bioreactor in London that will enable the company to produce 20-25 tonnes of cultivated meat per month. BeneMeat is pursuing a slightly different strategy. Its long-term plan is to become a technology provider, enabling partners such as pet food manufacturers to cultivate meat at their own facilities.

But to get there requires ‘real-world proof of concept’, so BeneMeat is currently building a manufacturing facility capable of making 400-600kg of cultivated meat per day to supply pilot projects.

However, Dr. Sandelowsky isn’t waiting around – Omni has shifted its focus back to hypoallergenic, plant-based food and treats for dogs with sensitivities. “We need it to get further along for it to be commercially viable,” he concludes.

1/2
Free articles
read this month

Register and read all articles, for free

See more GlobalPETS on Google

One click prioritizes GlobalPETS in your search results and AI answers.